1006P PD-L1, tumor mutational burden, and overall survival among patients undergoing surgical treatment for hepatocellular carcinoma prior to systemic therapy

Authors :: Henning Grønbæk
M.A. Marsico
A. Webber
K. Skaarup
H.Y. Lim
J.Y. Hong
X. Liu
Abby B. Siegel
Morten Ladekarl
A. Kachurak
Torben Steiniche
H-C.L. Pommergaard
S. Ha
Y-H. Paik
J.W. Lee
Jeanette Bæhr Georgsen
Source :: Steiniche, T, Marsico, M A, Siegel, A B, Gronbaek, H, Ha, S, Hong, J Y, Paik, Y-H, Georgsen, J, Pommergaard, H-CL, Ladekarl, M, Webber, A, Liu, X, Kachurak, A, Skaarup, K, Lee, J & Lim, H Y 2020, ' 1006P PD-L1, tumor mutational burden, and overall survival among patients undergoing surgical treatment for hepatocellular carcinoma prior to systemic therapy ', Annals of Oncology, pp. S697 . https://doi.org/10.1016/j.annonc.2020.08.1122
Publication Year :: 2020

Subjects :: Oncology
medicine.medical_specialty
biology
business.industry
Hematology
medicine.disease
Systemic therapy
PD-L1
Internal medicine
Hepatocellular carcinoma
biology.protein
Overall survival
Medicine
business
Surgical treatment

Language :: English
Database :: OpenAIRE
Journal :: Steiniche, T, Marsico, M A, Siegel, A B, Gronbaek, H, Ha, S, Hong, J Y, Paik, Y-H, Georgsen, J, Pommergaard, H-CL, Ladekarl, M, Webber, A, Liu, X, Kachurak, A, Skaarup, K, Lee, J & Lim, H Y 2020, ' 1006P PD-L1, tumor mutational burden, and overall survival among patients undergoing surgical treatment for hepatocellular carcinoma prior to systemic therapy ', Annals of Oncology, pp. S697 . https://doi.org/10.1016/j.annonc.2020.08.1122
Accession number :: edsair.doi.dedup.....a663df18259a1c060c7359681f40c055

Tools